Apellis Pharmaceuticals, Inc. (APLS)
18.94
+0.55
(+2.99%)
USD |
NASDAQ |
Mar 13, 16:00
18.95
+0.01
(+0.05%)
After-Hours: 20:00
Apellis Pharmaceuticals EPS Diluted (Quarterly) : -0.4654 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 0.1069 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.95M |
| Revenue (Quarterly) | 199.91M |
| Total Expenses (Quarterly) | 258.86M |
| Enterprise Value | 2.428B |
| Gross Profit Margin (Quarterly) | 85.13% |
| Profit Margin (Quarterly) | -29.49% |
| Earnings Yield | 0.65% |
| Operating Earnings Yield | 2.30% |
| Normalized Earnings Yield | 0.6521 |